Legal & Regulatory

Feds contend that FedEx knowingly performed illegal drug deliveries

rfXcel’s Traceability Platform becomes part of Verizon’s ThingSpace

New physician’s form is supposed to reduce the complexity of obtaining investigational drugs

Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) calls for better industry-government coordination

Labels will have a combination of reference-product and biosimilar-specific information

An all-compounding "manufacturer" has big plans for growth

Announces a new version of its "platform as a service," with connectivity to Apache Spark

Ophthamology tops the breakout by physician specialty

Sample distribution management, payments reporting and sales-rep training

The anatomy of an optimized sampling supply chain

Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 52% growth between 2014 and 2020

Database now covers 35 countries and 19 million HCPs

Discerning how and where products are discounted is an expensive headache for manufacturers

Looking at 'cost' and 'value' under different evaluation processes

MarkMonitor updates its surveillance surveys against counterfeiting and drug diversion

New healthcare proposals re-open talk of drug importation

Government at all levels are trying to mobilize to address the crisis

Friction continues with Express Scripts as well

Advisory program makes data reporting more uniform

Latest 'delegated regulation' of the Falsified Medicines Directive is promulgated

Acsis polls industry sentiment; TraceLink touts doubling of revenue

TGaS Advisors expands its roster of services

Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls

Office of Prescription Drug Promotion finds little to complain about

'Average Manufacturer Price' is now a mostly settled matter

Industry is doing better at filing studies, but the agency is falling behind reviews, says GAO

Company partners with Teikoku for the latter's first marketed oncology product, and earns a milestone payment from Teva

'European companies will not be able to follow the exact path to operational compliance as their US counterparts,' says IMS Health survey